OLMESARTAN MEDOXOMIL

Product NDC: 60290-010
11-digit product format: 602900010
Labeler code: 60290
Product ID: 60290-010_5cace4b6-59fc-195e-e063-6394a90aced7
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: OLMESARTAN MEDOXOMIL
Dosage form: TABLET
Route: ORAL
Labeler: Umedica Laboratories USA Inc.
Application: ANDA207135
Marketing category: ANDA
Marketing start: 2026-02-15
Substance: OLMESARTAN MEDOXOMIL
Active strength: 20 mg/1
Pharmacologic classes: Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A207135-001	OLMESARTAN MEDOXOMIL	OLMESARTAN MEDOXOMIL	5MG	TABLET / ORAL	AB	2019-07-18
A207135-002	OLMESARTAN MEDOXOMIL	OLMESARTAN MEDOXOMIL	20MG	TABLET / ORAL	AB	2019-07-18
A207135-003	OLMESARTAN MEDOXOMIL	OLMESARTAN MEDOXOMIL	40MG	TABLET / ORAL	AB	2019-07-18

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A207135-001	AB
A207135-002	AB
A207135-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A207135-001	OLMESARTAN MEDOXOMIL	5MG	TABLET / ORAL	AB	2019-07-18	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207135-002	OLMESARTAN MEDOXOMIL	20MG	TABLET / ORAL	AB	2019-07-18	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207135-003	OLMESARTAN MEDOXOMIL	40MG	TABLET / ORAL	AB	2019-07-18	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A207135-001	OLMESARTAN MEDOXOMIL	5MG	TABLET / ORAL	AB	2019-07-18	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A207135-002	OLMESARTAN MEDOXOMIL	20MG	TABLET / ORAL	AB	2019-07-18	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A207135-003	OLMESARTAN MEDOXOMIL	40MG	TABLET / ORAL	AB	2019-07-18	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A207135-001	OLMESARTAN MEDOXOMIL	5MG	TABLET / ORAL	AB	2019-07-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207135-002	OLMESARTAN MEDOXOMIL	20MG	TABLET / ORAL	AB	2019-07-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207135-003	OLMESARTAN MEDOXOMIL	40MG	TABLET / ORAL	AB	2019-07-18	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207135-001	OLMESARTAN MEDOXOMIL	5MG	TABLET / ORAL	AB	2019-07-18	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207135-002	OLMESARTAN MEDOXOMIL	20MG	TABLET / ORAL	AB	2019-07-18	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207135-003	OLMESARTAN MEDOXOMIL	40MG	TABLET / ORAL	AB	2019-07-18	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A207135-001	OLMESARTAN MEDOXOMIL	5MG	TABLET / ORAL	AB	2019-07-18	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A207135-002	OLMESARTAN MEDOXOMIL	20MG	TABLET / ORAL	AB	2019-07-18	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A207135-003	OLMESARTAN MEDOXOMIL	40MG	TABLET / ORAL	AB	2019-07-18	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207135-001	OLMESARTAN MEDOXOMIL	5MG	TABLET / ORAL	AB	2019-07-18	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207135-002	OLMESARTAN MEDOXOMIL	20MG	TABLET / ORAL	AB	2019-07-18	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207135-003	OLMESARTAN MEDOXOMIL	40MG	TABLET / ORAL	AB	2019-07-18	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207135-001	OLMESARTAN MEDOXOMIL	5MG	TABLET / ORAL	AB	2019-07-18	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207135-002	OLMESARTAN MEDOXOMIL	20MG	TABLET / ORAL	AB	2019-07-18	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207135-003	OLMESARTAN MEDOXOMIL	40MG	TABLET / ORAL	AB	2019-07-18	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207135-001	OLMESARTAN MEDOXOMIL	5MG	TABLET / ORAL	AB	2019-07-18	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207135-002	OLMESARTAN MEDOXOMIL	20MG	TABLET / ORAL	AB	2019-07-18	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207135-003	OLMESARTAN MEDOXOMIL	40MG	TABLET / ORAL	AB	2019-07-18	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207135-001	OLMESARTAN MEDOXOMIL	5MG	TABLET / ORAL	AB	2019-07-18	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207135-002	OLMESARTAN MEDOXOMIL	20MG	TABLET / ORAL	AB	2019-07-18	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207135-003	OLMESARTAN MEDOXOMIL	40MG	TABLET / ORAL	AB	2019-07-18	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207135-001	OLMESARTAN MEDOXOMIL	5MG	TABLET / ORAL	AB	2019-07-18	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207135-002	OLMESARTAN MEDOXOMIL	20MG	TABLET / ORAL	AB	2019-07-18	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207135-003	OLMESARTAN MEDOXOMIL	40MG	TABLET / ORAL	AB	2019-07-18	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A207135-001	OLMESARTAN MEDOXOMIL	5MG	TABLET / ORAL	AB	2019-07-18	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A207135-002	OLMESARTAN MEDOXOMIL	20MG	TABLET / ORAL	AB	2019-07-18	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A207135-003	OLMESARTAN MEDOXOMIL	40MG	TABLET / ORAL	AB	2019-07-18	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A207135-001	OLMESARTAN MEDOXOMIL	5MG	TABLET / ORAL	AB	2019-07-18	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A207135-002	OLMESARTAN MEDOXOMIL	20MG	TABLET / ORAL	AB	2019-07-18	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A207135-003	OLMESARTAN MEDOXOMIL	40MG	TABLET / ORAL	AB	2019-07-18	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A207135-001	OLMESARTAN MEDOXOMIL	5MG	TABLET / ORAL	AB	2019-07-18	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A207135-002	OLMESARTAN MEDOXOMIL	20MG	TABLET / ORAL	AB	2019-07-18	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A207135-003	OLMESARTAN MEDOXOMIL	40MG	TABLET / ORAL	AB	2019-07-18	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A207135-001	OLMESARTAN MEDOXOMIL	5MG	TABLET / ORAL	AB	2019-07-18	`301d65b070ca…`

Observed Orange Book normalized TE history#

Normalized TE history page 2 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A207135-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A207135-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A207135-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A207135-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A207135-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A207135-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A207135-002	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A207135-003	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A207135-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A207135-002	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A207135-003	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A207135-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A207135-002	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A207135-003	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A207135-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A207135-002	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A207135-003	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A207135-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A207135-002	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A207135-003	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A207135-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A207135-002	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A207135-003	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A207135-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A207135-002	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A207135-003	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A207135-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A207135-002	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A207135-003	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A207135-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A207135-002	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A207135-003	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A207135-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A207135-002	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A207135-003	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A207135-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A207135-002	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A207135-003	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A207135-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A207135-002	AB	1	`3f01610625f2…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: OLMESARTAN MEDOXOMIL
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
OLMESARTAN MEDOXOMIL	20 mg/1

FDA-Initiated Inactive NDC Indexing#

NDC, Related label table
NDC	Related label
60290-010-01	These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL tablets safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL TABLETS. OLMESARTAN MEDOXOMIL tablets, for oral use Initial U.S. Approval: 2002
60290-010-01	These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL tablets safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL TABLETS. OLMESARTAN MEDOXOMIL tablets, for oral use Initial U.S. Approval: 2002
60290-010-02	These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL tablets safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL TABLETS. OLMESARTAN MEDOXOMIL tablets, for oral use Initial U.S. Approval: 2002
60290-010-02	These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL tablets safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL TABLETS. OLMESARTAN MEDOXOMIL tablets, for oral use Initial U.S. Approval: 2002
60290-010-03	These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL tablets safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL TABLETS. OLMESARTAN MEDOXOMIL tablets, for oral use Initial U.S. Approval: 2002
60290-010-03	These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL tablets safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL TABLETS. OLMESARTAN MEDOXOMIL tablets, for oral use Initial U.S. Approval: 2002

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
OLMESARTAN MEDOXOMIL	OLMESARTAN MEDOXOMIL	Lifestar Pharma LLC	a337a621-bf57-4aa4-8224-4356fa2cdbc4	2025-12-09	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207135 application number: ANDA207135

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6M97XTV3HD	OLMESARTAN MEDOXOMIL	144689-63-4	OLMESARTAN MEDOXOMIL

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
60290-010-01	60290001001	30 TABLET in 1 BOTTLE (60290-010-01)	30 tablet	2026-02-15	No	No	Current
60290-010-02	60290001002	90 TABLET in 1 BOTTLE (60290-010-02)	90 tablet	2026-02-15	No	No	Current
60290-010-03	60290001003	10 TABLET in 1 BLISTER PACK (60290-010-03)	10 tablet	2026-02-15	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
OLMESARTAN MEDOXOMIL	Umedica Laboratories USA Inc. \| UMEDICA LABORATORIES PRIVATE LIMITED	2026-09-30	HUMAN PRESCRIPTION DRUG LABEL	4